National Institute of Neurological Disorders and Stroke (NINDS)
Overview
The National Institute of Neurological Disorders and Stroke (NINDS) is part of the U.S. National Institutes of Health (NIH). It conducts and funds research on brain and nervous system disorders. The mission of NINDS is to reduce the burden of neurological disease by conducting and supporting basic, translational, and clinical research on the brain and nervous system; fostering the training and career development of investigators in the basic and clinical neurosciences; seeking better understanding, diagnosis, treatment, and prevention of neurological disorders; and disseminating scientific discoveries to the public, health professionals, researchers, and policymakers.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| MicroTransponder | Feb 2010 | Grant | Co-investor |
| NextStep Robotics | Aug 2019 | Grant | Co-investor |
| FYR Diagnostics | Oct 2019 | Grant | Lead |
| AgeneBio, Inc. | Oct 2018 | Grant | Co-investor |
| Trace Biosciences | Sep 2022 | Grant | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is National Institute of Neurological Disorders and Stroke (NINDS) based?
National Institute of Neurological Disorders and Stroke (NINDS) is headquartered in Bethesda, Maryland, United States.
When was National Institute of Neurological Disorders and Stroke (NINDS) founded?
National Institute of Neurological Disorders and Stroke (NINDS) was founded in 1950.
How many portfolio companies does National Institute of Neurological Disorders and Stroke (NINDS) have?
National Institute of Neurological Disorders and Stroke (NINDS) has 41 portfolio companies in Caplight's dataset.
What are some companies in National Institute of Neurological Disorders and Stroke (NINDS)'s portfolio?
Portfolio companies visible on Caplight include MicroTransponder, NextStep Robotics, FYR Diagnostics, AgeneBio, Inc., Trace Biosciences.
What was National Institute of Neurological Disorders and Stroke (NINDS)'s most recent investment shown here?
National Institute of Neurological Disorders and Stroke (NINDS)'s most recent investment in this portfolio sample was in Trace Biosciences in 2022.
What sectors does National Institute of Neurological Disorders and Stroke (NINDS) focus on?
National Institute of Neurological Disorders and Stroke (NINDS) focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Energy & Sustainability, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Mobility, Transportation & Logistics, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does National Institute of Neurological Disorders and Stroke (NINDS) focus on?
National Institute of Neurological Disorders and Stroke (NINDS) typically invests at the MultiStage stage.
What is National Institute of Neurological Disorders and Stroke (NINDS)'s AUM?
National Institute of Neurological Disorders and Stroke (NINDS)'s assets under management are estimated between $1.0B and $10.0B.